Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2)

被引:45
作者
Opanasopit, Praneet [1 ]
Aumklad, Polawan
Kowapradit, Jarija
Ngawhiranpat, Tanasait
Apirakaramwong, Auayporn
Rojanarata, Theerasak
机构
[1] Silpakorn Univ, Fac Pharm, Nanotechnol Drug Gene Delivery Syst Grp, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand
[2] Mahidol Univ, Dept Ind Pharm, Bangkok 10700, Thailand
关键词
chitosan salts; FD-4; transport; enhanced permeability; Caco-2; cells;
D O I
10.1080/10837450701555901
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the effect of molecular weight ( MW) and salt forms of chitosans ( aspartate; CS A, glutamate; CS G, lactate; CS L and hydrochloride, CS HCl) on the transepithelial electrical resistance ( TEER) and permeability of Caco- 2 cells monolayer, using fluorescein isothiocyanate dextran 4000 ( FD- 4) as the model compound for paracellular tight junction transport. Chitosan salts were prepared by spray- drying method. FTIR and solid- state C-13 NMR spectra showed the functional groups of salts in their molecular structures. Salt form, MW of chitosan, and amount of chitosan influenced the permeation-enhancing effects. These studies showed that chitosan salts appeared to increase cell permeability in a dose- dependent manner and caused relatively reversible effects only at the lower doses of 0.001 - 0.01% w/ v. As the MW of chitosan increased from 20 to 460 kDa, the reduction in TEER significantly decreased in the following order: 20 < 45 < 200 < 460 kDa, observed in CS L and CS HCl. In CS A and CS G, the decrease in TEER was not significantly different in all MW because both chitosan salts showed rapid reduction in TEER within 20 min after the start of the experiment. Among chitosan salts, CS A was the most potent absorption enhancer in acidic ( pH 6.2) environment. Cytotoxicity of chitosan salts was concentration dependent and varied slightly among the salt forms of chitosan used. CS HCl ( MW 45 kDa) was the most toxic having an IC50 of 0.22 +/- 0.06 mg/ mL. The ranking of chitosan salts cytotoxicity was CS HCl > CS L> CS G > CS A.
引用
收藏
页码:447 / 455
页数:9
相关论文
共 30 条
[1]   Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells [J].
Alexandre, MD ;
Lu, Q ;
Chen, YH .
JOURNAL OF CELL SCIENCE, 2005, 118 (12) :2683-2693
[2]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[3]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P105
[4]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[5]   Evaluation of the biological properties of soluble chitosan and chitosan microspheres [J].
CarrenoGomez, B ;
Duncan, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (02) :231-240
[6]   Influence of molecular weight on oral absorption of water soluble chitosans [J].
Chae, SY ;
Jang, MK ;
Nah, JW .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) :383-394
[7]   Effect of chitosan on epithelial permeability and structure [J].
Dodane, V ;
Khan, MA ;
Merwin, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :21-32
[8]   Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles [J].
Dyer, AM ;
Hinchcliffe, M ;
Watts, P ;
Castile, J ;
Jabbal-Gill, I ;
Nankervis, R ;
Smith, A ;
Illum, L .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :998-1008
[9]   Chitosan: A unique polysaccharide for drug delivery [J].
Felt, O ;
Buri, P ;
Gurny, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (11) :979-993
[10]   Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep [J].
Hinchcliffe, M ;
Jabbal-Gill, I ;
Smith, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (06) :681-687